Medline raises full-year organic sales growth outlook

11 articles · Updated · MarketWatch · May 6

First-quarter revenue rose 11% to $7.35 billion, beating forecasts, while adjusted EPS of 33 cents topped estimates; net profit fell to $129 million from $322 million.
The Northfield, Illinois, medical-surgical supplier lifted its organic sales growth range to 8.5%-9.5% from 8%-9% after gains from new and existing customers, while keeping adjusted earnings guidance unchanged.
Higher tariffs, operating costs tied to customer expansion and an employee bonus linked to Medline's December 2025 IPO weighed on profit despite stronger sales.

Why are Medline’s backers selling billions in stock just as the company faces major profit headwinds?

With record sales growth, why did Medline’s quarterly profit collapse and its stock price suddenly plunge?

As U.S. tariffs erode a top supplier's profits, are hospitals facing a new wave of price hikes?